BMY - Bristol-Myers Squibb Company

NYSE - NYSE Delayed Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents6,911,0005,421,0004,237,0002,385,000
Short Term Investments1,973,0001,391,0002,113,0001,885,000
Net Receivables5,782,0005,609,0004,916,0004,117,000
Inventory1,195,0001,166,0001,241,0001,221,000
Other Current Assets697,000691,000627,000366,000
Total Current Assets17,160,00014,854,00013,704,00010,415,000
Long Term Investments2,449,0002,765,0002,788,0004,766,000
Property, plant and equipment5,027,0005,001,0004,980,0004,412,000
Goodwill6,538,0006,863,0006,875,0006,881,000
Intangible Assets1,091,0001,210,0001,385,0001,419,000
Accumulated Amortization----
Other Assets2,721,0002,858,0003,975,0003,855,000
Deferred Long Term Asset Charges1,371,0001,610,0002,996,0002,844,000
Total Assets34,986,00033,551,00033,707,00031,748,000
Current Liabilities
Accounts Payable1,892,0002,248,0001,664,0001,565,000
Short/Current Long Term Debt1,249,000-749,000-
Other Current Liabilities1,594,0001,161,0001,707,0002,508,000
Total Current Liabilities10,654,0009,563,0008,841,0008,017,000
Long Term Debt5,646,0006,975,0005,716,0006,558,000
Other Liabilities4,559,0005,166,0002,803,0002,749,000
Deferred Long Term Liability Charges----
Minority Interest96,000106,000170,000158,000
Negative Goodwill----
Total Liabilities20,859,00021,704,00017,360,00017,324,000
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock221,000221,000221,000221,000
Retained Earnings34,065,00031,160,00033,513,00031,613,000
Treasury Stock-22,336,000-21,538,000-19,282,000-19,027,000
Capital Surplus2,081,0001,898,0001,725,0001,459,000
Other Stockholder Equity-2,762,000-2,289,000-2,503,000-2,468,000
Total stockholders' equity14,031,00011,741,00016,177,00014,266,000
Net Tangible Assets6,402,0003,668,0007,917,0005,966,000